StockWatch
·
Medical/Dental Instruments
SplitNov 19, 2026, 05:11 PM

Co-Diagnostics Announces 1-for-25 Reverse Stock Split

AI Summary

Co-Diagnostics, Inc. announced a 1-for-25 reverse stock split, effective November 24, 2026. This action is intended to maintain compliance with Nasdaq's minimum bid price requirement and ensure sufficient authorized shares for future equity financings. The company will not issue fractional shares, instead rounding up to the nearest whole share. All outstanding stock options and warrants will be proportionally adjusted.

Key Highlights

  • Co-Diagnostics, Inc. will execute a 1-for-25 reverse stock split, effective November 24, 2026.
  • The reverse stock split aims to comply with Nasdaq's $1.00 minimum bid price requirement.
  • Approximately 521,779 shares of common stock are expected to be outstanding post-split.
  • Fractional shares will not be issued; instead, they will be rounded up to the nearest whole share.
  • Outstanding stock options and warrants will be proportionally adjusted.
  • The company's common stock will continue to trade under the symbol 'CODX' on The Nasdaq Capital Market.